Kaplan Gilla Insider Trades

Insider Trading History

Track insider trading activity for Kaplan Gilla. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $43.5k 3,167 shares
Last Trade
Mar 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44k 3,166 shares
$13.89
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $87k 6,333 shares
Last Trade
Mar 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$44k 3,166 shares
$13.89
$13.74
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $2.34M 81,403 shares
Last Trade
Mar 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.02M 53,172 shares
$38.03
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $810k 28,231 shares
Last Trade
Mar 26, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.01M 53,172 shares
$37.75
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $0 0 shares
Last Trade
Mar 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.02M 53,172 shares
$38.03
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $1.22M 42,526 shares
Last Trade
Mar 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$525k 14,295 shares
$36.71
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $1.53M 53,172 shares
Last Trade
Mar 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$525k 14,295 shares
$36.71
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $810k 28,231 shares
Last Trade
Mar 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$528k 14,295 shares
$36.97
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $810k 28,231 shares
Last Trade
Jun 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$93.6k 9,568 shares
$9.78
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $1.08M 37,799 shares
Last Trade
Jun 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$104 10 shares
$10.35
$28.69
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $276k 20,100 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.8k 20,100 shares
$4.47
$13.74
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $1.08M 37,809 shares
Last Trade
Jun 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.7k 6,814 shares
$10.38
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $1.28M 44,623 shares
Last Trade
Jun 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$155k 15,000 shares
$10.31
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $1.71M 59,623 shares
Last Trade
Jun 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$309k 30,000 shares
$10.31
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $637k 22,200 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 22,200 shares
$9.25
$28.69
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $43.5k 3,167 shares
Last Trade
Mar 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.8k 3,167 shares
$8.46
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $87k 6,333 shares
Last Trade
Mar 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.8k 3,167 shares
$8.46
$13.74
Avalo Therapeutics
Avalo Therapeutics AVTX
Director
Holding Value $338k 24,600 shares
Last Trade
Aug 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$243k 24,600 shares
$9.88
$13.74
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $2.57M 89,623 shares
Last Trade
Jun 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.22M 61,392 shares
$19.85
$28.69
Tyra Biosciences
Tyra Biosciences TYRA
Director
Holding Value $0 0 shares
Last Trade
Jun 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.22M 61,392 shares
$19.85
$28.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up